Last updated: May 9, 2024
Sponsor: University of Roma La Sapienza
Overall Status: Active - Recruiting
Phase
N/A
Condition
Obesity
Diabetes Prevention
Treatment
Measurement of the total small bowel length using CT scan and MRI with 3D reconstruction and AI tool
Clinical Study ID
NCT06065917
C.88
Ages 18-80 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
BMI > 35 kg/m2 and at least one obesity-related comorbidity
BMI > 40 kg/m2
failure of at least six months of dietary and/or medical treatment of obesity
indication for intervention validated after multidisciplinary evaluation in a specific board meeting
Study Design
Total Participants: 195
Treatment Group(s): 1
Primary Treatment: Measurement of the total small bowel length using CT scan and MRI with 3D reconstruction and AI tool
Phase:
Study Start date:
January 02, 2024
Estimated Completion Date:
February 28, 2026
Study Description
Connect with a study center
Azienda Ospedaliera Universitaria Sant'Andrea
Rome, RM 00189
ItalyActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.